SEC v. Rakesh Ahuja, No. LR-26533, Southern District of New York (Apr. 21, 2026) — Press Release
raw: Rakesh Ahuja
Rakesh Ahuja, No. LR-26533 (S.D.N.Y. Apr. 21, 2026)
summary
Rakesh Ahuja, a former investment advisory firm employee, settled SEC charges for insider trading involving clinical trial data by trading through a relative's account.
paragraph
Ahuja allegedly used material nonpublic information regarding biopharmaceutical companies to generate approximately $65,000 in profits. He faces charges for violating Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5. The settlement requires him to pay $65,404.25 in disgorgement, $12,289.01 in interest, and a $65,404.25 civil penalty.
narrative
The SEC filed a settled action against Rakesh Ahuja, a former employee of an investment advisory firm, for insider trading. While working for the firm, Ahuja obtained confidential clinical trial data and used it to execute trades through a close relative's brokerage account. This misconduct occurred across four occasions involving three different publicly traded companies. His unlawful trades resulted in approximately $65,000 in total profits. To resolve the matter, Ahuja agreed to a final judgment that includes a two-year ban from the investment industry. He must also pay a total of approximately $143,100, covering disgorgement, prejudgment interest, and civil penalties. This settlement resolves allegations of violating Section 10(b) of the Securities Exchange Act and Rule 10b-5.
Classified insider-trading(confidence 100%). EDGAR detection: forms 4/3/5/144· recall 81% / precision 19%. detection rule →
Parties
Securities and Exchange CommissionRakesh Ahuja
Keywords
advisory firmahujarakesh ahujasecurities exchangeinvestment advisorysecadvisoryinvestmentfirmrakeshsecuritiesexchangecompaniesapril securitiesexchange commission
Exhibits & Attached Documents (1)
Extracted insights
Dollar amounts 3
- $65K $65,404 $10K–$100K
- $65K $65,000 $10K–$100K
- $12K $12,289 $10K–$100K
Entities 3
- person advisory firm
- person rakesh ahuja
- agency Securities and Exchange Commission
Triples 10
- Securities and Exchange Commission filed settled action against Rakesh Ahuja
- Rakesh Ahuja worked for an investment advisory firm
- advisory firm provided material nonpublic information to Ahuja
- Rakesh Ahuja breached duty to the advisory firm
- Rakesh Ahuja traded based on material nonpublic information
- Rakesh Ahuja's trades resulted in profits of approximately $65,000
- Rakesh Ahuja consented to entry of a final judgment
- Rakesh Ahuja agreed to pay disgorgement of $65,404.25
- Rakesh Ahuja verb prejudgment interest of $12,289.01
- Rakesh Ahuja agreed to pay civil penalty of $65,404.25
PDF (from attached: complaint)
Text layers
Extracted body text (2,542c)
U.S. SECURITIES AND EXCHANGE COMMISSIONLitigation Release No. 26533 / April 21, 2026Securities and Exchange Commission v. Rakesh Ahuja, Civil Case No. 26-cv-03213 (S.D.N.Y. filed April 20, 2026)SEC Files Settled Action as to Former Investment Advisory Firm Employee Charged with Insider TradingOn April 20, 2026, the Securities and Exchange Commission filed a settled action as to Rakesh Ahuja, a former employee of an investment advisory firm, for allegedly insider trading based on confidential information he obtained during his employment.According to the SEC’s complaint, filed in the United States District Court for the Southern District of New York, Ahuja worked for an investment advisory firm that provided investment advisory services to two pooled investment funds that specialized in making investments in biopharmaceutical and biotechnology companies. The SEC alleges that the advisory firm provided Anuja with material nonpublic information, including confidential clinical trial data, from these companies as part of its due diligence process. The SEC further alleges that on multiple occasions, Ahuja breached his duty to the advisory firm by causing a brokerage account in the name of one of his close relatives to trade based on material nonpublic information in advance of announcements by companies he was researching for the advisory firm. Ahuja allegedly engaged in this conduct in connection with three publicly traded companies on a total of four occasions. According to the complaint, Ahuja’s unlawful trades resulted in profits of approximately $65,000.Without admitting or denying the allegations, Ahuja consented to the entry of a final judgment, subject to court approval, in which he agreed to be permanently enjoined from violating the antifraud provisions of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder; enjoined from acting as or being associated with an investment adviser, broker, or dealer for a period of two years; and to pay disgorgement of $65,404.25, prejudgment interest of $12,289.01, and a civil penalty of $65,404.25.The SEC’s investigation was conducted by Frank Goldman, Patrick McCluskey, and Danielle R. Voorhees of the Division of Enforcement’s Market Abuse Unit, under the supervision of Joseph G. Sansone, Chief of the Market Abuse Unit, with the assistance of trial counsel Sharan Lieberman under the supervision of Gregory A. Kasper of the SEC’s Denver Regional Office. The SEC appreciates the assistance of the Financial Industry Regulatory Authority.
OCR text (2,542c · html-text · 99% conf)
U.S. SECURITIES AND EXCHANGE COMMISSIONLitigation Release No. 26533 / April 21, 2026Securities and Exchange Commission v. Rakesh Ahuja, Civil Case No. 26-cv-03213 (S.D.N.Y. filed April 20, 2026)SEC Files Settled Action as to Former Investment Advisory Firm Employee Charged with Insider TradingOn April 20, 2026, the Securities and Exchange Commission filed a settled action as to Rakesh Ahuja, a former employee of an investment advisory firm, for allegedly insider trading based on confidential information he obtained during his employment.According to the SEC’s complaint, filed in the United States District Court for the Southern District of New York, Ahuja worked for an investment advisory firm that provided investment advisory services to two pooled investment funds that specialized in making investments in biopharmaceutical and biotechnology companies. The SEC alleges that the advisory firm provided Anuja with material nonpublic information, including confidential clinical trial data, from these companies as part of its due diligence process. The SEC further alleges that on multiple occasions, Ahuja breached his duty to the advisory firm by causing a brokerage account in the name of one of his close relatives to trade based on material nonpublic information in advance of announcements by companies he was researching for the advisory firm. Ahuja allegedly engaged in this conduct in connection with three publicly traded companies on a total of four occasions. According to the complaint, Ahuja’s unlawful trades resulted in profits of approximately $65,000.Without admitting or denying the allegations, Ahuja consented to the entry of a final judgment, subject to court approval, in which he agreed to be permanently enjoined from violating the antifraud provisions of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder; enjoined from acting as or being associated with an investment adviser, broker, or dealer for a period of two years; and to pay disgorgement of $65,404.25, prejudgment interest of $12,289.01, and a civil penalty of $65,404.25.The SEC’s investigation was conducted by Frank Goldman, Patrick McCluskey, and Danielle R. Voorhees of the Division of Enforcement’s Market Abuse Unit, under the supervision of Joseph G. Sansone, Chief of the Market Abuse Unit, with the assistance of trial counsel Sharan Lieberman under the supervision of Gregory A. Kasper of the SEC’s Denver Regional Office. The SEC appreciates the assistance of the Financial Industry Regulatory Authority.